Navigation Links
Emerging Opportunities in the US Enteric Diseases Diagnostic Testing Market 2016 - Profiles Key Suppliers and Potential Market Entrants Developing Innovative Technologies and Products
Date:10/28/2015

DUBLIN, Oct. 28, 2015 /PRNewswire/ --

Research and Markets (http://www.researchandmarkets.com/research/7glfhh/2016_emerging) has announced the addition of the "2016 Emerging Opportunities in the US Enteric Diseases Diagnostic Testing Market" report to their offering.

About This Report

This new 322-page report presents detailed analysis of the US Enteric Diseases market, including sales forecasts and supplier shares for Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio and Yersinia. The report provides test volume and sales projections for Hospitals, Physician Offices, Commercial and Public Health Labs.

In addition to market share and sales forecasts, the report:

  • Examines market applications of Molecular Diagnostics, Monoclonal Antibodies, Immunoassays, IT and other emerging technologies;
  • Reviews features and operating characteristics of major analyzers used for microbiology testing;
  • Profiles key suppliers and potential market entrants developing innovative technologies and products; and
  • Analyzes emerging opportunities, alternative market penetration strategies, market entry barriers/risks, and strategic planning issues.

Companies Mentioned

  • Abbott Laboratories
  • AdnaGen/Alere
  • Agilent Technologies
  • Bayer Healthcare
  • Beckman Coulter/Danaher
  • Biomedical Diagnostics
  • BioMerieux
  • Bio-Rad
  • DiaSorin
  • Eiken
  • Fujirebio
  • Grifols
  • Instrumentation Laboratory
  • Kyowa Medex
  • Matritech/Alere
  • Ortho-Clinical Diagnostics
  • Quest Diagnostics
  • Roche
  • Siemens
  • Sysmex
  • Thermo Fisher
  • Tosoh
  • Wako
  • Wallac/PE

For more information visit http://www.researchandmarkets.com/research/7glfhh/2016_emerging

Media Contact: Laura Wood , +353-1-481-1716, press@researchandmarkets.net


'/>"/>
SOURCE Research and Markets
Copyright©2015 PR Newswire.
All rights reserved


Related medicine technology :

1. Thought-Leader Opinion and Clinical Data Indicate that Emerging Agents from Two Drug Classes Have Efficacy Advantages Over Currently Used Therapies for HR-Positive, HER2-Negative Breast Cancer
2. Emerging Pharma at ChemOutsourcing 2013 in Record Numbers for Upcoming September Show
3. Emerging Targeted Therapies Offer Efficacy Advantages Over Currently Used Chemotherapies for Platinum-Resistant Advanced Ovarian Cancer
4. For Moderate to Severe Psoriasis, Thought Leaders Opinions and Clinical Data Indicate That Emerging Biologics That Target IL-17 Have the Potential to Offer Improvements in Efficacy and Safety Over Current Therapies
5. In Terms of Effect on Overall Survival, Current and Emerging Therapies Have No Advantage Over Avastin/FOLFIRI in the Treatment of Second-Line Metastatic Colorectal Cancer, According to Clinical Data and Thought Leader Opinion
6. The Emerging Eastern European Market For Interventional Cardiology Devices Will Grow To $282 Million By 2021
7. Frost & Sullivan Analyzes Emerging Opportunities for Stakeholders in the Transforming Healthcare Industry
8. Device Sector Facing Medical Education Challenges as Industry Continues Expansion into Emerging Markets
9. Up to Sixty Percent of Surveyed U.S. Managed Care Organization Directors Expect to Cover Key Emerging Therapies for Parkinsons Disease on Their Largest Commercial Plan
10. Emerging Markets Present Challenge for Medical Device Companies Outsourcing Clinical Activities
11. Frost & Sullivan Lauds Adcock Ingrams Capability to Innovatively Cater to the Dynamic Needs of Emerging Pharmaceuticals Markets
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2020)... ... , ... Dr. Mark Surrey has been in practice for over 25 ... professor in the Department of OBGYN at UCLA’s David Geffen School of Medicine. ... Society and is a Clinical Director of Fellowship Training for UCLA & Cedars Sinai ...
(Date:8/27/2020)... , ... August 27, 2020 , ... Bleep LLC, maker ... and sleep apnea patient, is the company’s new spokesperson. , “In my line of ... So, when I found the Bleep DreamPort it was a Bleeping no brainer for ...
(Date:8/26/2020)... ... 26, 2020 , ... AseptiScope, a privately funded San Diego, California based, clinical ... MedTech Outlook. , “AseptiScope is pleased to receive this recognition,” said Kelly ... gloves on their hands, goggles on their eyes, covers on their shoes, and gowns ...
Breaking Medicine Technology:
(Date:9/1/2020)... ... September 01, 2020 , ... Dr. ... training in aesthetic surgery of the face, breast, and body. In 2018, she ... premier boutique plastic surgery and aesthetic practice in Southwest Florida. Dr. Gill and ...
(Date:8/31/2020)... ... August 31, 2020 , ... The Lymphoma ... funding innovative lymphoma research and serving the lymphoma community through a comprehensive series ... Anniversary of Blood Cancer Awareness Month (BCAM) and its international Light it ...
(Date:8/31/2020)... ... August 31, 2020 , ... Ocean Springs, Mississippi-based pharmaceutical distributor ... first responders across the United States. Since the start of the global COVID-19 ... medical centers , hospitals , firefighters , and public ...
(Date:8/31/2020)... ... August 31, 2020 , ... ... management solution for chiropractors, announced today the launch of its integrated, HIPAA compliant, ... start running their virtual practice in under 90 seconds. , According to ...
(Date:8/31/2020)... ... 2020 , ... Smile Brands Inc., one of the nation’s ... today announced the grand opening of another affiliated Bright Now! Dental office ... hours, a comfortable office, and full-service care at the new Beaumont location. The ...
Breaking Medicine News(10 mins):